期刊
JOURNAL OF PERSONALIZED MEDICINE
卷 12, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/jpm12030334
关键词
antiretroviral therapy; discrete choice experiment (DCE); HIV; long-acting injectable (LAI); patient preference; physician preference
资金
- ViiV Healthcare - ViiV Healthcare
The study revealed that the majority of PLWH prefer long-acting injectable (LAI) antiretroviral therapy over oral treatment, while physicians are also inclined to recommend LAI for patients. Patients believe that LAI can reduce daily reminders of HIV and feelings of being stigmatized.
A long-acting injectable (LAI) antiretroviral therapy (ART) regimen is now available as a treatment option for virologically suppressed adults with HIV-1. This study assessed preference for a LAI regimen using an online survey of virally suppressed people living with HIV (PLWH) and physicians treating HIV in the US and Canada. Preference was elicited in a discrete choice experiment (DCE) with three choice options (switch to a LAI regimen, switch to another daily oral ART regimen, or stay on their current daily oral ART regimen) and four treatment attributes. A total of 553 PLWH and 450 physicians completed the survey. From the DCE results, 59% of PLWH were predicted to prefer a LAI over an alternative oral ART or staying on their current oral treatment, and 55-66% of physicians were predicted to recommend LAI for PLWH, depending on the treatment challenge scenario presented. PLWH indicated LAI would remove daily reminders of HIV (75%) and reduce feelings of being stigmatized (68%). A majority of PLWH and physicians preferred a LAI over oral ART to overcome treatment challenges such as daily pill burden and adherence. These benefits of LAI ART along with preferences of PLWH and physicians can help to inform ART choice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据